Low dose thalidomide maintenance in myeloma patients after autologous stem cell transplantation

被引：0
|
作者：
Bayer, R. -L. [1 ]
John, V. [1 ]
Devoe, C. [1 ]
Cannon, M. [1 ]
Klocke, J. [1 ]
Gissinger, D. [1 ]
机构：
[1] N Shore Univ Hosp, Manhasset, NY USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2007年 / 13卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2006.12.146
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
142
引用
收藏
页码：53 / 54
页数：2
相关论文
共 50 条
  • [11] Thalidomide maintenance following high-dose melphalan with autologous stem cell support in myeloma
    Chang, Julie E.
    Juckett, Mark B.
    Callander, Natalie S.
    Kahl, Brad S.
    Gangnon, Ronald E.
    Mitchell, Teri L.
    Longo, Walter L.
    CLINICAL LYMPHOMA & MYELOMA, 2008, 8 (03): : 153 - 158
  • [12] Outcomes of Maintenance Therapy with Bortezomib after Autologous Stem Cell Transplantation for Patients with Multiple Myeloma
    Sivaraj, Dharshan
    Green, Michael M.
    Li, Zhiguo
    Sung, Anthony D.
    Sarantopoulos, Stefanie
    Kang, Yubin
    Long, Gwynn D.
    Horwitz, Mitchell E.
    Lopez, Richard D.
    Sullivan, Keith M.
    Rizzieri, David A.
    Chao, Nelson J.
    Gasparetto, Cristina
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (02) : 262 - 268
  • [13] Maintenance treatment after autologous stem cell transplantation in patients with multiple myeloma - new drugs for multiple myeloma
    Maiolino, Angelo
    Garnica, Marcia
    LEUKEMIA RESEARCH, 2018, 73 : S3 - S4
  • [14] The clinical impact of thalidomide maintenance after autologous stem cell transplantation in patients with newly diagnosed multiple myeloma in real clinical practice of Korea
    Lee, Ho Sup
    Min, Chang-Ki
    Lee, Je-Jung
    Kim, Kihyun
    Kim, Seok Jin
    Yoon, Dok Hyun
    Eom, Hyeon-Seok
    Lee, Hyewon
    Lee, Won Sik
    Shin, Ho-Jin
    Lee, Ji Hyun
    Park, Yong
    Jo, Jae-Cheol
    Do, Young Rok
    Mun, Yeung-Chul
    Lee, Mark Hong
    ANNALS OF HEMATOLOGY, 2016, 95 (06) : 911 - 919
  • [15] The clinical impact of thalidomide maintenance after autologous stem cell transplantation in patients with newly diagnosed multiple myeloma in real clinical practice of Korea
    Ho Sup Lee
    Chang-Ki Min
    Je-Jung Lee
    Kihyun Kim
    Seok Jin Kim
    Dok Hyun Yoon
    Hyeon-Seok Eom
    Hyewon Lee
    Won Sik Lee
    Ho-Jin Shin
    Ji Hyun Lee
    Yong Park
    Jae-Cheol Jo
    Young Rok Do
    Yeung-Chul Mun
    Mark Hong Lee
    Annals of Hematology, 2016, 95 : 911 - 919
  • [16] Salvage therapy with thalidomide in multiple myeloma patients relapsing after autologous peripheral blood stem cell transplantation
    Tosi, P
    Ronconi, S
    Zamagni, E
    Cellini, C
    Grafone, T
    Cangini, D
    Pileri, SA
    Baccarani, M
    Tura, S
    Cavo, M
    HAEMATOLOGICA, 2001, 86 (04) : 409 - 413
  • [17] Salvage of multiple myeloma patients relapse after an autologous stem cell transplantation, in the era of thalidomide and reduced-intensity allogeneic stem cell transplantation
    Hardan, I
    Kneller, A
    Shimoni, A
    Berkowicz, M
    Avigdor, A
    Yeshurun, M
    Raanani, P
    Davidowich, Y
    Shemtov, N
    Ben Bassat, I
    Nagler, A
    BONE MARROW TRANSPLANTATION, 2004, 33 : S156 - S157
  • [18] Cell dose and hematologic recovery after autologous stem cell transplantation for multiple myeloma
    Tonev, Ivan
    Simeonov, Stanislav
    Ilieva, Marina
    Mitkoff, Ivan
    Arnaudov, Georgi
    Ganeva, Penka
    Petrov, Yavor
    Spassov, Branimir
    Mincheff, Milcho
    BONE MARROW TRANSPLANTATION, 2019, 54 : 509 - 510
  • [19] The Clinical Impact of Thalidomide Maintenance on Progression Free Survival and Postrelapse Survival after Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple myeloma
    Lee, Ho Sup
    Kim, Yang Soo
    Min, Chang-Ki
    Lee, Je-Jung
    Kim, Kihyun
    Yoon, Dok Hyun
    Eom, Hyeon Seok
    Lee, Hyewon
    Lee, Won Sik
    Shin, Ho-Jin
    Lee, Ji Hyun
    Park, Yong
    Jo, Jae-Cheol
    Do, Young Rok
    Mun, Yeung-Chul
    BLOOD, 2014, 124 (21)
  • [20] Bortezomib and thalidomide maintenance after stem cell transplantation for multiple myeloma: a PETHEMA/GEM trial
    L Rosiñol
    A Oriol
    A I Teruel
    A L de la Guía
    MaJ Blanchard
    J de la Rubia
    M Granell
    MaA Sampol
    L Palomera
    Y González
    MaA Etxebeste
    R Martínez-Martínez
    M T Hernández
    F de Arriba
    A Alegre
    MaT Cibeira
    MaV Mateos
    J Martínez-López
    J J Lahuerta
    J San Miguel
    J Bladé
    Leukemia, 2017, 31 : 1922 - 1927
12345